AUTOMATED ANALYSIS OF MULTIPLEXED PROBE-TRAGET INTERACTION PATTERNS: PATTERN MATCHING AND ALLELE IDENTIFICATION
    12.
    发明公开
    AUTOMATED ANALYSIS OF MULTIPLEXED PROBE-TRAGET INTERACTION PATTERNS: PATTERN MATCHING AND ALLELE IDENTIFICATION 有权
    AUTOMATED交互模式分析复用器样品取样目标和比较ALLELIDENTIFIKATION

    公开(公告)号:EP1774323A2

    公开(公告)日:2007-04-18

    申请号:EP05789862.9

    申请日:2005-08-02

    IPC分类号: G01N33/48 G01N33/50 G06F19/00

    摘要: Disclosed are methods and algorithms (and their implementation) supporting the automated analysis and interactive review and refinement ('redaction') of the analysis within an integrated software environment, for automated allele assignments. The implementation, preferably with a software system and a program referred to as the Automated Allele Assignment ('AAA') program, provides a multiplicity of functionalities including: data management by way of an integrated interface to a portal a database to permit visualizing, importing, exporting and creating customizable summery reports; system configuration ('Set-up') including user authorization, training set analysis and probe masking; Pattern Analysis including string matching and probe flipping; and Interactive Redaction combining real-time database computations and 'cut-and­paste' editing, generating 'warning' statements and supporting annotation. It also includes a thresholding function, a method of setting thresholds, a method of refining thresholds by matching an experimental binary string ('reaction pattern') setting for that probe, probe masking of signals produced by probes which do not contribute significantly to discriminating among alleles.

    A TRANSFUSION REGISTRY AND EXCHANGE NETWORK
    16.
    发明公开
    A TRANSFUSION REGISTRY AND EXCHANGE NETWORK 审中-公开
    TRANS FUSION注册和交换网络

    公开(公告)号:EP2013801A2

    公开(公告)日:2009-01-14

    申请号:EP07761283.6

    申请日:2007-04-25

    IPC分类号: G06F19/00 G06F17/00

    摘要: Disclosed is a registry for candidate transfusion donors, which invokes an inventory management policy to create and actively manage lists of candidate donors in order to minimize imbalances between demand and supply across multiple regions and across multiple categories of donors and recipients. Together with a genotyping laboratory, the registry does targeted recruitment of prospective donors who are typed for a set of genetic markers relating to clinically relevant antigens including mutations of Human Erythrocyte Antigens (HEA), genetic variants of Rh, and possibly additional antigens such as HLA and HPA. The registry monitors incoming demand for transfusion antigen genotypes, preferably stratify the demand into a set of categories representing stable subpopulations, and will apply strategies, disclosed herein, to tune the composition of candidate donor lists to match the demand, thereby avoiding excess, and unnecessary, typing of candidate donors.

    SELECTION OF GENOTYPED TRANSFUSION DONORS BY CROSS-MATCHING TO GENOTYPED RECIPIENTS
    17.
    发明公开
    SELECTION OF GENOTYPED TRANSFUSION DONORS BY CROSS-MATCHING TO GENOTYPED RECIPIENTS 审中-公开
    基因分型,输血献血者用CROSS基因型RECEIVERS比较选择

    公开(公告)号:EP1941414A2

    公开(公告)日:2008-07-09

    申请号:EP06826464.7

    申请日:2006-10-23

    IPC分类号: G06F19/00

    摘要: Disclosed are methods for establishing the compatibility between two bloodtypes on the basis of cross-matching (under a designated rule of stringency) the minor blood group genotypes of recipient and prospective donors. To determine compatibility, the blood group genotypes are mapped to corresponding phenotypes according to the expression states associated with a set of underlying haplotypes, and compatibility is established by establishing the compatibility of bloodtypes constructed as a combination of constituent phenotypes. The bit strings are matched, preferably using an algorithm expression. Where ambiguity in mapping genotypes to haplotypes exists, it can be reduced based on frequency of occurrence of the haplotypes in the sample population, or resolved by gametic phasing. Such reduction or resolution of ambiguity is particularly desirable where mismatches in the antigens expressed by the constituent haplotypes have greater clinical significance.